Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WXT
|
|||
| Former ID |
DNC000879
|
|||
| Drug Name |
Lithium chloride
|
|||
| Synonyms |
LITHIUM CHLORIDE; 7447-41-8; Lithiumchloride; Lithium chloride (LiCl); LiCl; chlorure de lithium; Chlorku litu; chlorolithium; Lithiumchlorid; Chlorku litu [Polish]; Luthium chloride; Chlorure de lithium [French]; CCRIS 5924; UNII-G4962QA067; HSDB 4281; EINECS 231-212-3; lithium(1+) ion chloride; NSC 327172; CHEMBL69710; CHEBI:48607; NSC327172; MFCD00011078; G4962QA067; Lithium chloride, 99%, extra pure; ClLi; Lithium chloride, 99+%, ACS reagent; Lithium chloride, 99%, for molecular biology; Lithium chloride, 99%, for analysis, anhyd
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
ClLi
|
|||
| Canonical SMILES |
[Li+].[Cl-]
|
|||
| InChI |
1S/ClH.Li/h1H;/q;+1/p-1
|
|||
| InChIKey |
KWGKDLIKAYFUFQ-UHFFFAOYSA-M
|
|||
| CAS Number |
CAS 7447-41-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
574598, 645372, 6117077, 10296192, 10534590, 11111379, 15066026, 17405166, 24278056, 24845370, 24852187, 24852673, 24858795, 24866862, 24868517, 24882223, 24882224, 24882225, 24882226, 24884921, 24886496, 24896448, 24896459, 29291114, 48243350, 48318401, 48423615, 49658753, 49855771, 50106409, 50106410, 50414734, 50414735, 53777710, 53790639, 56310984, 56311064, 56312344, 56313565, 56314428, 56369244, 57402806, 57651888, 57651889, 57651890, 57651891, 57652457, 83620214, 85087326, 85087327
|
|||
| ChEBI ID |
CHEBI:48607
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycogen synthase kinase-3 alpha (GSK-3A) | Target Info | Inhibitor | [1], [2] |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| Insulin/IGF pathway-protein kinase B signaling cascade | ||||
| PDGF signaling pathway | ||||
| Ras Pathway | ||||
| Pathway Interaction Database | Degradation of beta catenin | |||
| Canonical Wnt signaling pathway | ||||
| FOXM1 transcription factor network | ||||
| Class I PI3K signaling events mediated by Akt | ||||
| Reactome | AKT phosphorylates targets in the cytosol | |||
| XBP1(S) activates chaperone genes | ||||
| Constitutive Signaling by AKT1 E17K in Cancer | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS. J Neuroimmune Pharmacol. 2007 Mar;2(1):93-6. | |||
| REF 2 | Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med. 2002 Mar;8(3):126-32. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.